What Is the Price of GS-441524 (NeoFipronis)
Feline Infectious Peritonitis (FIP) remains one of the most challenging diseases affecting cats worldwide. Caused by a mutated form of feline coronavirus, FIP leads to severe symptoms such as loss of appetite, lethargy, fever, accumulation of fluid in the abdomen and chest, lymphadenopathy, granulomas, neurological damage, and uveitis. Traditional treatments have been largely ineffective, making the development of targeted antiviral therapies a significant breakthrough in feline medicine. One of the most promising options is NeoFipronis (Pronidesivir), which contains GS-441524—a highly effective antiviral compound.
GS-441524 is recognized globally as the active ingredient in NeoFipronis, regarded as the first officially registered oral medication approved specifically for FIP treatment. In March 2026, the Ministry of Agriculture and Forestry of Laos (MAF) granted formal approval, making NeoFipronis the first FIP-specific drug with a government registration number. This revolutionary medication has quickly gained popularity among veterinarians and cat owners due to its safety, ease of use, rapid onset of action, and excellent tolerability.
Therapeutic Effectiveness
NeoFipronis is characterized by its high bioavailability and fast absorption, enabling quick penetration into tissues and effective suppression of the feline coronavirus mutation responsible for FIP. Extensive research and clinical practice have verified its potent antiviral activity with minimal side effects. The medication is suitable for various forms of FIP, including wet (effusive), dry (non-effusive), and neuro-ocular types. Symptoms such as inappetence, fever, depression, ascites, pleural effusion, lymph node swelling, granulomatous lesions, neurodegeneration, and ocular inflammation can be effectively alleviated with NeoFipronis therapy.
Dosage and Use
The recommended dosage depends on the cat’s weight. Typically, it is administered at 15 mg per kilogram of body weight, which equates to half a tablet for most cats. For cats with neurological or ocular FIP, the dose may be increased to 30 mg/kg, as per veterinary guidance. The medication should be given once daily, ideally on an empty stomach—either one hour before feeding or two hours after—and maintained continuously for at least 12 weeks. It is vital not to skip doses to ensure complete viral suppression and prevent relapse.
Precautions and Monitoring
While NeoFipronis is classified as an over-the-counter drug, veterinary supervision during treatment is strongly recommended. Owners should monitor their cats closely for appetite changes, body temperature fluctuations, behavioral shifts, and adverse reactions. Regular blood tests to assess liver and kidney function are advisable during treatment to detect potential side effects early. Patients should complete the full course of therapy without interruption, even if clinical symptoms improve before the scheduled end of treatment.
Availability and Price
The cost of GS-441524 in NeoFipronis varies depending on the country, supplier, and dosage form. As of now, in regions where it is officially available, a typical pack of NeoFipronis (containing about 30 tablets) ranges from $150 to $300 USD. The price may fluctuate based on import taxes, distribution channels, and whether the medication is purchased directly from authorized distributors or through veterinarian clinics. Despite its relatively high cost, NeoFipronis remains a cost-effective choice compared to the expenses associated with prolonged veterinary care for untreated or inadequately treated FIP.
Safety and Purchase
NeoFipronis (Pronidesivir) is intended solely for feline use and should not be administered to humans. It can be purchased only through authorized veterinary pharmacies or official NeoFipronis websites to ensure product authenticity and quality. Using legitimate sources helps prevent counterfeit medications, which can compromise treatment safety and efficacy.
Conclusion
The introduction of NeoFipronis has revolutionized FIP management, offering hope to many cat owners battling this deadly disease. The primary active ingredient, GS-441524, provides potent antiviral effects, making it the most promising FIP treatment to date. The estimated price of NeoFipronis depends on various factors but generally ranges between $150 and $300 USD for a standard supply. Always consult a qualified veterinarian for proper diagnosis, dosing, and monitoring to maximize the chances of a successful outcome. Continual advancements in antiviral therapies like NeoFipronis underline a new era in feline infectious disease treatment.
